Astral down in red

Astral shares were under pressure today morning, figuring among the top three losers on the BSE, falling around 9% to Rs. 1,345 after the company’s board approved the demerger of its chemicals business into a separate listed entity, Astral Chemie Ltd. The stock slipped from its previous close of Rs. 1,486.30 and touched an intraday low of Rs. 1,339, as investors reacted to the restructuring and near-term earnings uncertainty.

Trigger

• Astral shares fell around 9% in intraday trade after the demerger update.
• The company will demerge its chemicals business into Astral Chemie Ltd.
• Shareholders will receive 1 fully paid-up share of Astral Chemie for every 1 share held in Astral.
• Astral Chemie is proposed to be listed on BSE and NSE after necessary approvals.
• The record date and listing timeline will be announced later.
• Brokerage concerns over near-term earnings uncertainty and growth outlook added to pressure.
• The stock also trades at elevated valuations, with PE above 50 for the past four trailing quarters.

The market is reacting to the uncertainty around Astral’s post-demerger growth profile. While the restructuring is aimed at sharper capital allocation and better focus for each business, investors are worried that the remaining entity may lose part of the growth optionality attached to the chemicals, adhesives, paints and specialty chemicals portfolio.

The demerger also creates a near-term valuation overhang. Once a business is split into a separate listed entity, investors need to reassess the fair value of both the parent company and the new company. Until there is more clarity on the financials, margins, capital requirements and listing timeline of Astral Chemie, the market may apply a discount to both the restructuring process and the parent stock.